Publicaciones (8) Publicaciones de EDUARDO ORTIZ LASTRA

2015

  1. Evaluation of genotoxic effects of antihypertensive drugs: Angiotensin II receptor blockers

    Antihypertensive Drugs: Pharmacology, Medical Uses and Potential Side Effects (Nova Science Publishers, Inc.), pp. 55-78

2014

  1. Genotoxic evaluation of five Angiotesin II receptor blockers: In vivo and in vitro micronucleus assay

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 767, pp. 1-7

2012

  1. Single Nucleotide Polymorphism and FMR1 CGG Repeat Instability in Two Basque Valleys

    Annals of Human Genetics, Vol. 76, Núm. 2, pp. 110-120

2010

  1. Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: Correlation between chromosomal fragility and content of micronuclei

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 695, Núm. 1-2, pp. 46-54

2003

  1. Experimental design approach for the optimisation of a HPLC-fluorimetric method for the quantitation of the angiotensin II receptor antagonist telmisartan in urine

    Journal of Pharmaceutical and Biomedical Analysis

2001

  1. Determination of the β-blocker atenolol in plasma by capillary zone electrophoresis

    Journal of Chromatography A

  2. Evaluation of the cytogenetic damage induced by the antihypertensive drug nimodipine in human lymphocytes

    Mutagenesis, Vol. 16, Núm. 4, pp. 345-351

2000

  1. In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: Effects of long-term therapy

    Mutagenesis, Vol. 15, Núm. 3, pp. 195-202